Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal distention
Alzheimer's disease
CAT scan, emission, abnormal
Clinical Pathologic Conference(C.P.C.)
confusion
congestive heart failure
corticotropin level
corticotropin-releasing factor
cortisol, elevated
Cushing's syndrome
depression
diabetes mellitus
dyspnea
echocardiogram, LVH
facial hair, excessive
fatigue
fever
hirsutism
hypertension
hypokalemia
leg swelling
leukocytosis
lymphopenia
mental status, abnormal
metabolic alkalosis
MRI
MRI, abnormal
muscle weakness, proximal
neoplasm, hormone producing, ectopic
neuroendocrinology
night sweats
palpitations
pituitary
pulmonary embolism
thirst
urinary frequency
Showing articles 300 to 350 of 3358 << Previous Next >>

Practice Guide Update Summary: Mild Cognitive Impairment
Neurol 90:126-135, Petersen, R.C.,et al, 2018

Five and 10 Minute Apgar Scores and Risks of Cerebral Palsy and Epilepsy: Population Based Cohort Study in Sweden
BMJ 360:k207, Persson, M.,et al, 2018

Evidence-Based Management of Patent Foramen Ovale in Patients with Ischemic Stroke
JAMA Neurol 75:147-148, Kamel, H., 2018

Association of Preoperatively Diagnosed Patent Foramen Ovale with Perioperative Ischemic Stroke
JAMA 319:452-462,446, Ng, P.Y.,et al, 2018

Persistent Postural-Perceptual Dizziness (PPPD): A Common, Characteristic and Treatable Cause of Chronic Dizziness
Pract Neurol 18:5-13, Popkirov, S.,et al, 2018

Diagnosing Stroke in Acute Dizziness and Vertigo
Stroke 49:788-795, Saber Tehrani, A.S.,et al, 2018

Antibody-Mediated Encephalitis
NEJM 378:840-851, Dalmau, J.,et al, 2018

Abdominal Migraine
BMJ 360;k179, Angus-Leppan, H.,et al, 2018

Maternal and Fetal Risks of Natalizumab Exposure in Utero
Neurol 90:443-444, Marrie, R.A.,et al, 2018

Adult-Onset Vanishing White Matter Disease
Neurol 90:e1091-e1092, Villar-Quiles, R.N.,et al, 2018

Headache and Altered Mental Status
Neurol 90:e1267-e1270, Spera, K.M.,et al, 2018

Cranial Cavernous Malformations
Stroke 49:1029-1035, Stapleton, C.J. & Barker, F.G., 2018

Mixed-Location Cerebral Hemorrhage/Microbleeds
Neurol 90:e119-e126, Pasi, M.,et al, 2018

Acute demyelinating polyneuropathy induced by nivolumab
JNNP 89:435-437, Fukumoto, Y.,et al, 2018

Intracranial Arterial Dolichoectasia and Stenosis
Stroke 49:1135-1140, Zhai, F.,et al, 2018

Long-Term Risk of Hemorrhagic Stroke In Young Patients with Congenital Heart Disease
Stroke 49:1155-1162, Giang, K.W.,et al, 2018

Cerebrovascular Accidents During Mechanical Circulatory Support
Stroke 49:1197-1203, Izzy, S.,et al, 2018

Acute acalculous cholecystitis
Neurol 90:e1548-e1552, Croteau, D.,et al, 2018

Management of Bleeding in Patients Taking Oral Anticoagulants
JAMA 319:2032-2033, Anderson, I.,et al, 2018

Progressive multifocal leukoencephalpathy after fingolimod treatment
Neurol 90:1815-e1821, Berger, J.R.,et al, 2018

A 77-year-old man presenting with episodic expressive aphasia
Neurol 90:e1822-e1826, Shanklin, A.,et al, 2018

Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies
BMJ 360:k1717, Adderley, N.J.,et al, 2018

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared with Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
Stroke 49:1464-1470, Reddy, V.Y.,et al, 2018

Diagnosis and Management of Active Intracranial Atherosclerotic Disease
Stroke 49:e221-e223, Narwal, P.,et al, 2018

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
NEJM 378:2191-2201, Hart, R.G.,et al, 2018

Risk of Ischemic and Hemorrhagic Strokes in Occult and Manifest Cancers
Stroke 49:1585-1592, Andersen, K.K. & Olsen, T.S., 2018

Factor Xa Inhibitors Versus Vitamin K Antagonists for Prevention of Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 49:e235-e236, Bruins Slot, K.M.H. & Berge, E., 2018

A 41-year-old man with Thunderclap Headache
Neurol 91:e87-e91, Grossman, S.et al, 2018

Autoimmune Pancerebellitis Associated with Pembrolizumab Therapy
Neurol 91:91-93, Vitt, J.R.,et al, 2018

Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy
Neurol 91:e359-e363, Rauer,S.,et al, 2018

Andexxa-An Antidote for Apixaban and Rivaroxaban
JAMA 320:399-400, , 2018

Clinicopathological Conference, Insulinoma
NEJM 379:376-384, Case 23-2018, 2018

A Headache of a Diagnosis
NEJM 379:475-479, Stern,R.M.,et al, 2018

Guillain-Barre Syndrome following tuberculosis: A rare association
J Neurosci Rural Pract 8:296-299, Lakhotia, A.N.,et al, 2017

Cerebral Venous Sinus Thrombosis in Homocystinuria: Dietary Intervention in Conjunction with Anticoagulation
Sage Open Med Case Reports 5:1-4, Yap, S.,et al, 2017

Clinicopathologic Conference, Paroxysmal Nocturnal Hemoglobinuria
NEJM 377:2581-2590, Case 40-2017, 2017

Older Patients Should Take PPIs to Cut Risk of Bleed From Aspirin, Study Says
BMJ 357:J2865, Mayor, S., 2017

Outcome of Intracerebral Hemorrhage Associated with Different Oral Anticoagulants
Neurol 88:1693-1700,1686, Wilson, D.,et al, 2017

Hemorrhage Risk of Brain Arteriovenous Malformations During Pregnancy and Puerperium in a North American Cohort
Stroke 48:1507-1513, Porras, J.L.,et al, 2017

Alcohol Use and Risk of Intracerebral Hemorrhage
Neurol 88:2043-2051, Chen, C.J.,et al, 2017

Pregabalin Use Early in Pregnancy and the Risk of Major Congenital Malformations
Neurol 88:2020-2025, Patorno, E.,et al, 2017

Intravenous Immune Globulin: Adverse Effects
UptoDate June, Perez, E.E. & Silvergleid, A.J., 2017

Amyotrophic Lateral Sclerosis
NEJM 377:162-172, Brown, R.H.,et al, 2017

Migraine
NEJM 377:553-561, Charles, A., 2017

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
NEJM 377:431-441, Pollack, C.V.,et al, 2017

Association Between Cirrhosis and Stroke in a Nationally Representative Cohort
JAMA Neurol 74:927-932, Parikh, N.S.,et al, 2017

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Court
JAMA Neurol 74:933-940,901, Jennings, D.,et al, 2017

Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017

Recrudescence of Deficits After Stroke
JAMA Neurol 74:1048-1055, Topcuoglu, M.A.,et al, 2017



Showing articles 300 to 350 of 3358 << Previous Next >>